IVF vs CBLL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

IVF

45.3
AI Score
VS
CBLL Wins

CBLL

45.4
AI Score

Investment Advisor Scores

IVF

45score
Recommendation
HOLD

CBLL

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IVF CBLL Winner
Revenue 1.64M 26.49M CBLL
Net Income -17.40M -19.74M IVF
Net Margin -1063.0% -74.5% CBLL
Operating Income -1.20M -20.75M IVF
ROE -548.6% -14.0% CBLL
ROA -54.8% -11.1% CBLL
Total Assets 31.74M 178.08M CBLL
Cash 840,407 45.25M CBLL
Current Ratio 0.08 10.44 CBLL
Free Cash Flow -3.56M -19.42M IVF

Relative Price Performance (Last 90 Days)

IVF 1M: -40.6% · 3M: -49.3% CBLL 1M: -7.1% · 3M: -11.4%

Current Technical Phase

IVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -17.2%), weak momentum, RSI 37

RSI (14): 37.1 · Price: $0.96

CBLL

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -1.8%) with fading momentum, RSI 48

RSI (14): 48.5 · Price: $18.16

Fundamentals Snapshot

Metric IVF CBLL
Market Cap
Forward P/E -0.1 -16.1
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth 0.2% 0.3%
Gross Margin 0.4% 0.9%
Operating Margin -0.8% -0.8%
EPS 254.30 -1.61
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CBLL is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.